Spiriva Respimat is a prescription inhaler used for long-term maintenance treatment of COPD and asthma. It contains tiotropium, a long-acting bronchodilator that relaxes the muscles around your airways to keep them open for a full 24 hours. You take it once daily, and it’s approved for adults with COPD (including chronic bronchitis and emphysema) and for asthma patients ages 6 and older.
One critical distinction: Spiriva Respimat is not a rescue inhaler. It won’t help during a sudden asthma attack or acute breathing episode. It’s designed for daily prevention, taken at the same time each day to keep symptoms under control over the long term.
How Spiriva Respimat Works
Your airways are lined with smooth muscle that can tighten in response to certain chemical signals. One of these signals is acetylcholine, a natural substance your body produces. Tiotropium blocks acetylcholine from binding to receptors in the airways, which prevents the muscles from squeezing and narrowing your breathing passages. Because tiotropium stays attached to these receptors for a long time, a single dose provides bronchodilation that lasts through the entire day.
For people with COPD, this means less breathlessness during daily activities and fewer flare-ups. For people with asthma, it adds an extra layer of airway control on top of other maintenance medications like inhaled corticosteroids.
The Respimat Device
The “Respimat” part of the name refers to the specific inhaler device, not the medication itself. Tiotropium also comes in a different device called the HandiHaler, which delivers the drug as a dry powder. The Respimat is a soft mist inhaler: it produces a slow-moving aerosol cloud that you breathe in, without needing a propellant like older-style inhalers.
This slower mist offers a practical advantage. Because the spray moves more gently, more medication actually reaches your lungs and less gets deposited in your mouth and throat. This is especially helpful for people who struggle to coordinate a fast, deep breath with pressing an inhaler button, a common challenge with traditional metered-dose inhalers. The Respimat requires a lower dose of the drug to achieve the same effect as the dry powder version.
Once you insert the cartridge into the Respimat device, you have 3 months to use it before it expires, regardless of how many doses remain.
Who Can Use It
Spiriva Respimat has two FDA-approved uses:
- COPD in adults: Long-term maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema. It’s also specifically indicated to reduce the frequency of COPD exacerbations.
- Asthma in patients 6 and older: Long-term, once-daily maintenance treatment. In children ages 6 to 17, it’s used as an add-on therapy when asthma isn’t fully controlled with other medications.
Dosing
The dosing is straightforward and identical across conditions. Each puff delivers 2.5 micrograms of tiotropium. You take two puffs once a day, for a total daily dose of 5 micrograms. That’s it. You don’t need to adjust timing around meals, and there’s no second dose later in the day. Taking it at the same time each morning (or whatever time you choose) helps maintain consistent airway protection.
Common Side Effects
Dry mouth is the most characteristic side effect, which makes sense given how the drug works: blocking acetylcholine affects saliva production. In clinical trials involving over 3,200 patients on Spiriva Respimat, 4.1% experienced dry mouth compared to 1.6% on placebo. For most people, it’s mild and manageable with regular sips of water or sugar-free gum.
Sore throat (pharyngitis) was reported by 11.5% of patients on Spiriva Respimat versus 10.1% on placebo, a small difference that suggests some of this symptom may simply reflect the underlying lung condition rather than the medication itself. Other reported side effects include sinus infections, cough, and dizziness, though these occurred at rates close to placebo.
Who Should Be Cautious
Because tiotropium is an anticholinergic drug, it can worsen certain pre-existing conditions. Two groups need particular attention:
People with narrow-angle glaucoma should be alert for warning signs like eye pain, blurred vision, visual halos, or redness. The drug can increase pressure inside the eye, and if you notice any of these symptoms, it warrants prompt medical attention.
People with urinary retention issues, particularly men with enlarged prostates, may find that Spiriva Respimat makes it harder to pass urine. If you already have difficulty with urination or a known bladder-neck obstruction, the anticholinergic effects of this medication can aggravate the problem. Painful urination or an inability to empty your bladder fully are signs to take seriously.
Spiriva Respimat vs. the HandiHaler
Both devices deliver tiotropium, but they work differently. The HandiHaler is a dry powder inhaler: you load a capsule, pierce it, and inhale the powder with a strong, steady breath. The Respimat generates a fine mist mechanically, so it doesn’t depend as much on your ability to inhale forcefully. This makes the Respimat a better option for people with severely compromised lung function or those who have trouble generating enough airflow to use a dry powder device effectively.
The improved lung deposition from the Respimat’s slower spray means the device delivers the same therapeutic effect at a lower total dose of tiotropium. Both devices are used once daily and provide 24-hour bronchodilation, so the choice between them typically comes down to which device a patient can use most effectively and consistently.
What to Expect When Starting
Spiriva Respimat is a maintenance therapy, meaning its full benefit builds over days to weeks of consistent use. You may notice some improvement in breathing within the first day or two, but the reduction in flare-ups and overall symptom control improves with regular daily use over time. Missing doses undermines this steady protection, so building the habit of taking it at the same time each day matters more than the specific time you choose.
If you’re using Spiriva Respimat for asthma, it’s typically added alongside your existing inhaled corticosteroid, not as a replacement. For COPD, it may be prescribed alone or alongside other bronchodilators depending on the severity of your condition. Either way, you’ll still need a separate fast-acting rescue inhaler for sudden breathing difficulties.